United States · FDA National Drug Code directory

Emtricitabine and tenofovir disoproxil fumarate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70771-1709_8fb1b15c-e324-4410-9a1b-2b3a2ffee3f6
Product NDC: 70771-1709
Form: TABLET, FILM COATED
Composition / generic term: Emtricitabine and tenofovir disoproxil fumarate
Labeler: Zydus Lifesciences Limited
Marketing category: ANDA
Marketing start / end (source format): 20210324
Source listing expiry: 20261231

Source-listed ingredients

EMTRICITABINE — 200 mg/1
TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, FILM COATED in 1 BOTTLE (70771-1709-3) · 70771-1709-3
10 BLISTER PACK in 1 CARTON (70771-1709-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1709-2) · 70771-1709-4
90 TABLET, FILM COATED in 1 BOTTLE (70771-1709-9) · 70771-1709-9

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →